同乐城tlc88网站

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval Document from the National Medical Products Administration (“NMPA”) on Drug Supplementary Applica...

CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approv...

Detailed>>

Detailed +

2021.06

2021.06.04

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given...

Runsheng’s ANDA application to FDA for Advair Diskus Generic Grug was given “Priority Review”

2021.05

2021.05.20

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreemen...

CR Biopharmaceutical and Hybio Pharmaceutical signed a cooperation agreement

2021.03

2021.03.31

CR Sanjiu cooperate with Ryukakusan to protect throat health in China

CR Sanjiu joins hands with Ryukakusan to protect throat health in China

2020.12

2020.12.23

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical Co., Ltd.’s

CR Double-Crane acquired 38.7% interest of Dongying Tiandong Pharmaceutical...

On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Dongying Tiandong Pharmaceutical Equity Transfer Agreement” was formally signed.

On December 22, 2020, the signing ceremony between CR Double-Crane and Shandong Haike was held in Dongying, Shandong, and the “Don...

2020.12

2020.12.14

NIP Pharm received the clinical trial approval of innovative drug NIP046

On December 9, the innovative drug research and development platform of CR Pharm, NIP Pharm, received the "Notice of Drug Clinical Trial Approval" issued by the National Medical Products Administration (NMPA), approving NIP046 tablets for rheumatoid arthritis adaptation Clinical trials.

On December 9, the innovative drug research and development platform of CR Pharm, NIP Pharm, received the "Notice of Drug Clinical...

2020.02

2020.02.12

CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA

2017.08

2017.08.25

China Resources Pharmaceutical Delivers Solid Interim Results

2017.08

2017.08.07

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceutical Industry in 2016”

Multiple CR Pharma subsidiaries awarded “Top 100 of Chinese Pharmaceutical ...

2017.06